key: cord-269914-75to9xr2 authors: Jansson, Miia; Rubio, Juanjo; Gavaldà, Ricard; Rello, Jordi title: Artificial Intelligence for clinical decision support in Critical Care, required and accelerated by COVID-19 date: 2020-10-21 journal: Anaesth Crit Care Pain Med DOI: 10.1016/j.accpm.2020.09.010 sha: doc_id: 269914 cord_uid: 75to9xr2 nan Prior to COVID-19, up to 20 million people annually required ICU admission and mechanical ventilation (MV) [2] . The burden for critical care services has risen exponentially in response to the COVID-19 pandemic [3] . Facing this "new reality", ICUs and emergency departments (EDs) need to be re-designed. For instance, creative ways of accommodating frequent ventilator adjustments while reducing the risk of exposure to health care workers need to be found (HCWs) [4] . AI, big data, and machine learning can help health care systems respond to these unprecedented challenges. If appropriately designed and deployed, AI can allow for early diagnosis (e.g. computer-aided methods to help radiologists identify COVID-19 specific lesions in chest X-rays), distance monitoring, and can assist the clinical decision-making process, and improve efficiency. Predictive analytics can be used to estimate the probability of either presenting (diagnostic models) or developing a particular disease or outcome (prognostic models) [1] . Diagnostic models have been proposed in a variety of clinical situations including early detection or stratification of sepsis [5] , bacterial and viral infections (e.g., COVID-19) [5] , and delirium in the ICU [5] , as well as pulmonary embolism in primary care [6] . Prognostic models have focused on predicting ICU-related mortality [7] , infections (e.g., positive blood culture, MRSA) [5] , responses to treatments [5] , antibiotic resistance [5] , asynchronies during assisted ventilation [8] , prolonged MV [9] , extubation failure [10] , and death in influenza [11] , COVID-19 [12, 13] , and community-acquired pneumonia [14] . Best performances were observed in models that rely on clinical, laboratory, and radiological variables [14] . Most of these studies, however, have not included continuous physiological signals (e.g., ventilator parameters, vital signals) for prediction [1] . Indeed, such information would substantially improve prediction performance [15] . Beyond predicting specific outcomes, one should expect advances in the direction of predicting the entire temporal evolution of a patient. Techniques such as structured output prediction or latent embedding have been successfully used both in the ICU and elsewhere [16, 17] . This approach can be used for developing personalised patient management and treatment plans, based on the success on previous patients with similar prognosis. AI and machine learning (ML) have largely been applied to the data collected since the beginning of the COVID-19 pandemic. Traditional epidemic models have described the spreading of a contagious disease in a population using differential equations. Most recently, AI has been used to predict COVID-19 incidence and evaluate the impact of mitigating measures such as population confinement and social distancing [18] . Geolocated critical care demand prediction, optimal hospital resource planning, and intelligent patient flow management with decision support algorithms can also be achieved by integrating real time clinical data with population statistics and health interventions. Computer-assisted detection systems can be used for early identification, grading, and monitoring of J o u r n a l P r e -p r o o f infectious and non-infectious lung diseases. Interestingly, they can also be used to distinguish viral pneumonia from bacterial pneumonia [19] . Most recently, however, ML techniques have focused on detecting COVID-19 infections in chest X-rays and CT scans [20, 21] . Overall, sensitivity of CT scan has ranged from 57%-100% for symptomatic and 46%-100% for asymptomatic COVID-19 patients [21] . The worldwide shortage of personal protective equipment has promoted the utilisation of robotic technologies to minimise human-to-human contacts and the workload of health care workers. A robotic telepresence is seen as a natural successor to telemedicine. Robots have also been used to automate and scale up testing capabilities, with rapid prototyping, development, and validation of automated clinical diagnostic tests for COVID-19 [21] . Robotassisted rehabilitation has been shown to be more effective than conventional therapy alone to improve functional recovery in critically ill patients, whereas the effectiveness of robot-assisted endovascular/intravenous catheterisation and tracheal intubation, for instance, are under investigation [23, 24, 25] . Novel sensor array techniques have been used in infectious and non-infectious lung diseases. For instance, exhaled breath biomarkers (e.g., volatile and non-volatile components) are promising alternatives to traditional microbiological diagnostics. Commercially available electronic nose sensors have been developed to diagnose ventilator-associated pneumonia (with and without Pseudomonas aeruginosa) [26] . Using several ML algorithms, a high diagnostic accuracy has been detected therein. In the future, detecting, tracing, and managing new viral outbreaks will require deploying inexpensive and ubiquitous sensor networks. Intelligent biosensors may be become part of our smart cities and buildings, integrated in our environment, air, sewage, and waste management systems. Wearable personal biosensors will monitor our bodies while synthetic molecular biosensors will be part of our tissues and cells. Engineering biology capabilities are exponentially accelerating as DNA/RNA reading and writing costs rapidly approach zero. Every mutation of COVID-19 has been sequenced and synthesised in record time, and many regions in the world are beginning to integrate WGS human data with EHR systems for personalised medicine diagnostics and treatment [27] ; research projects are now correlating genomic biomarkers with infection severity and prognostic treatment efficacy [28, 29] . ML allows searching libraries of available drugs and known molecules, accelerates effective vaccine and treatment development, enables digital modelling and testing, and engineering antibodies. Furthermore, by sharing information and using standards, synbio factories are able to locally manufacture physical biomolecules designed elsewhere. ACTERREA Research Group. Big data and targeted machine learning in action to assist medical decision in the ICU The patient needing prolonged mechanical ventilation: a narrative review The patient needing prolonged mechanical ventilation: a narrative review Strengthening ICU health security for a Coronavirus epidemic Remote control and monitoring of GE Aisys anesthesia machines repurposed as intensive care unit ventilators Machine learning for clinical decision support in infectious diseases: a narrative review of current applications Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care Predictors of 1-year mortality in patients on prolonged mechanical ventilation after surgery in intensive care unit: a multicenter, retrospective cohort study Predictors of Asynchronies During Assisted Ventilation and Its Impact on Clinical Outcomes: The EPISYNC Cohort Study Prediction of prolonged ventilation after coronary artery bypass grafting: Data from an artificial neural network Predicting weaning difficulty for planned extubation patients with an artificial neural network Using a machine learning approach to predict mortality in critically ill influenza patients: a cross-sectional retrospective multicentre study in Taiwan Artificial intelligence approach to predict the COVID-19 patient´s recovery Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal Risk Prediction Models for Mortality in Community-Acquired Pneumonia: A Systematic Review Cardiorespiratory dynamics measured from continuous ECG monitoring improves detection of deterioration in acute care patients: a retrospective cohort study Predicting sequences of clinical events by using a personalized temporal latent embedding model Optimal intensive care outcome prediction over time using machine learning Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions Transfer Learning with Deep Convolutional Neural Network (CNN) for Pneumonia Detection using Chest X-ray Automated detection of COVID-19 cases using deep neural networks with X-ray images A systematic review of CT chest in COVID-19 diagnosis and its potential application in a surgical setting A new role for Biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2 Robot-assisted therapy using the MOTOmed letto 2 for the integrated early rehabilitation of stroke patients admitted to the intensive care unit Current utilization and future directions of robotic-assisted endovascular surgery Automated tracheal intubation in an airway manikin using a robotic endoscope: a proof of concept study Diagnosis of ventilator-associated pneumonia using electronic nose sensor array signals: solutions to improve the application of machine learning in respiratory research 1+ Million Genomes" Initiative Determinantes Genéticos y Biomarcadores genómicos de riesgo en pacientes con infección por coronavirus SARS-COV-2 Using whole genome sequencing to help combat COVID-19 Digi-HTA: Health technology assessment framework for digital healthcare services The clinical artificial intelligence department: a prerequisite for success